tm
Seeing Is Believing
tm
Seeing Is Believing
with an average price target of $-22. This is a potential upside of $-22.4 (-5600%) from yesterday's end of day stock price of $0.4.
Nabriva Therapeutics AG's activity chart (see below) currently has 3 price targets and 7 ratings on display.
Analysts average stock forecasts to be materialized ratio is 75% with an average time for these price targets to be met of 145.5 days.
Most recent stock forecast was given by CARL BYRNES from NORTHLAND CAPITAL MARKETS on 06-Jan-2023. First documented stock forecast 07-Dec-2020.
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date
Price targets met ratio
Average potential upside
Average Time (Days) For PT To Be Met
Performance score
Buy
$1
$0.6 (150.00%)
$18
2 years 17 days ago
(06-Jan-2023)
1/2 (50%)
$-0.3 (-23.08%)
207
Hold
$50
$49.6 (12400.00%)
4 years 1 months 17 days ago
(07-Dec-2020)
1/1 (100%)
$-44.5 (-47.09%)
84
What is NBRV (Nabriva Therapeutics AG) average time for price targets to be met?
Which analyst has the current highest performing score on NBRV (Nabriva Therapeutics AG) with a proven track record?
Which analyst has the current lower performing score on NBRV (Nabriva Therapeutics AG) with a proven track record?
Which analyst has the most public recommendations on NBRV (Nabriva Therapeutics AG)?
Which analyst is the currently most bullish on NBRV (Nabriva Therapeutics AG)?
Which analyst is the currently most reserved on NBRV (Nabriva Therapeutics AG)?
